A case report of cryptococcal meningoencephalitis presenting as uveitis
© The Author(s) 2012
Received: 25 March 2012
Accepted: 16 April 2012
Published: 7 May 2012
In any patient with a first attack of posterior uveitis, it is important to differentiate whether the underlying cause is infective or non-infective in nature. However, when patients with a history of non-infective posterior inflammation present with recurrent symptoms of a flare-up, there is naturally a much lower suspicion of an infective aetiology and immunosuppression is usually commenced for the ‘flare-up’. We present a case of infective posterior uveitis due to a rare pathogen occurring in a patient with a known history of sarcoid uveitis which was initially misdiagnosed and treated as a ‘flare-up’.
A 60-year-old male farmer with previous history of bilateral anterior and posterior uveitis, secondary to sarcoidosis, presented with new symptoms of visual blurring in the left eye, headaches and dizziness. Prior to this episode, he had been under regular follow-up for flare-ups of posterior uveitis affecting one or both eyes over a 10-year period. His episodes of inflammatory flare-ups have typically responded well to short courses of systemic corticosteroid therapy. The most recent flare-up, prior to this current episode 4 months earlier, was successfully treated with oral prednisolone with recovery to visual acuities of 6/6 right and 6/6 left.
At this stage, several possibilities were being considered, including inflammatory flare-up of ocular sarcodosis with optic nerve involvement, neurosarcoid, or infiltrative or compressive optic neuropathy. CT and MRI scans of the head and brain showed no radiological signs of inflammatory or space-occupying lesions in the left optic nerve and chiasma. As there was no evidence to suggest an infective cause at that stage, he was commenced on 60 mg/day of oral prednisolone.
Initially, his left eye improved slightly to 6/6, but reduced colour vision persisted and headaches worsened, accompanied by transient confusion and an episode of slurred speech. The prednisolone dosage was briskly tapered and he was admitted into a hospital for further investigations. Because of the poor response to corticosteroid therapy and the appearance of new neurological symptoms, other neurological conditions were being considered, including tuberculous meningitis, fungal meningitis, prion disease and neurosarcoidosis. He was still apyrexial and initial blood investigations and infection screen (including VDRL, HIV and AFB) were all normal.
The patient was thus diagnosed with meningoencephalitis secondary to C. neoformans infection and commenced on two weeks of intravenous antifungal therapy of amphotericin 4 mg/kg once a day and flucytosine 25 mg/kg four times a day, followed later by oral fluconazole 400 mg OD for the next twelve months.
Cryptococcal infections (crypotococcoses) are most commonly caused by C. neoformans. This species is almost always synonymous with immunosuppression, particularly HIV infection. It has also been described with organ transplantation, malignancy, sarcoidosis, liver failure and even diabetes mellitus [2–4]. However, in a recent Canadian study, MacDougall et al.  reported the occurrence of infection in immunocompetent individuals by the Cryptococcus gatii species.
Asymptomatic pulmonary infection by Cryptococcus is common, even in the immunocompetent; usually, it is only in the immunocompromised that meningeal involvement occurs. Routine blood tests may be normal, making the diagnosis more difficult to confirm. Unfortunately, ‘cure’ can often prove difficult, with patients suffering from relapse of infection .
Due to our patient’s occupation as a farmer, he was frequently in contact with avian excreta, a potential source of infection by Cryptococcus species . Furthermore, he was immunosuppressed, not only through receiving recurrent systemic corticosteroids but also through having sarcoidosis per se, which may have made him additionally vulnerable to the cryptococcal infection. There have been several reports of a specific association between cryptococcal infection and sarcoidosis [8–10]. Botha and Wessels  postulated that this susceptibility is either due to immunosuppression from steroid use or exclusively to impaired T cell-mediated immunity as a result of sarcoidosis in patients not treated with steroids. Impaired T cell-mediated immunity in such patients could be due to the sequestration of T cells within organs affected by sarcoid, such as the lung.
The diagnostic challenge of differentiating an infectious cause from a non-infectious (inflammatory) cause is a common one when a patient presents for the first time with posterior uveitis. Non-infectious causes are much more common, and once confirmed, the patients usually respond well to immunosuppression with steroids or steroid-sparing agents. This case illustrates a rare and challenging scenario in which a patient presents with an infective cause of posterior uveitis but has had multiple episodes of non-infectious flare-ups of posterior uveitis which responded well to immunosuppression previously. Therefore, less common, infectious causes of active posterior uveitis need to be considered not only when investigating patients with their first presentation but also when they present with ‘flare-ups’ despite a previous history of non-infectious flare-ups as they can be immunocompromised from their therapy or from the underlying inflammatory conditions.
Acknowledgements go to Sharon Hughes for assisting with generating the figures.
Conflict of interest
None of the authors has conflict of interest with the submission.
No financial support was received for this submission.
- Saldanha DRM, Prashanth HV, Shenoy S, Baliga S (2009) Diagnostic value of latex agglutination in cryptococcal meningitis. J Lab Physician 1(2):67–68View ArticleGoogle Scholar
- Kiertiburanakul S, Wirojtananugoon S, Pracharktam R, Sungkanuparph S (2006) Cryptococcosis in human immunodeficiency virus-negative patients. Int J Infect Dis 10(1):72–78PubMedView ArticleGoogle Scholar
- Kushawaha A, Mobarakai N, Parikh N, Belinson A (2009) Cryptococcus neoformans meningitis in a diabetic patient—the perils of an overzealous immune response: a case report. Cases J 2:209PubMedPubMed CentralView ArticleGoogle Scholar
- Dromer F, Mathoulin S, Dupont B, Laporte A (1996) Epidemiology of cryptococcosis in France: a 9-year survey (1985–1993). French Cryptococcosis Study Group. Clin Infect Dis 23(1):82–90PubMedView ArticleGoogle Scholar
- MacDougall L, Fyfe M, Romney M, Starr M, Galanis E (2011) Risk factors for Cryptococcus gattii infection, British Columbia, Canada. Emerg Infect Dis 17(2):193–199PubMedPubMed CentralView ArticleGoogle Scholar
- Pappas PG, Perfect JR, Cloud GA et al (2001) Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy. Clin Infect Dis 33(5):690–6999PubMedView ArticleGoogle Scholar
- Kluger N, Poirier P, Guilpain P, Baixench M, Cohen P, Paugam A (2009) Cryptococcal meningitis in a patient treated with infliximab and mycophenolate mofetil for Behcet’s disease. Int J Infect Dis 13(5):e325PubMedView ArticleGoogle Scholar
- Kumari PR, Shahapur PR, Rao PS (2005) Corticosteroid induced Cryptococcus meningitis. Indian J Med Microbiol 23:207–208PubMedView ArticleGoogle Scholar
- Ross JJ, Katz JD (2002) Cryptococcal meningitis and sarcoidosis. Scand J Infect Dis 34(12):937–939PubMedView ArticleGoogle Scholar
- Botha RJ, Wessels E (1999) Cryptococcal meningitis in an HIV negative patient with systemic sarcoidosis. J Clin Pathol 52:928–930PubMedPubMed CentralView ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. Open Access This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution and reproduction in any medium, provided the original author(s) and source are credited.